The medicine "Sotageksal". Instructions for use

The drug "Sotageksal" isbeta-blocker. The active substance is sotalol. The medication is given in tablet form and in the form of an injection solution. Tablets "Sotageksal" have antiarrhythmic, antianginal and hypotensive activity. The medication promotes sympathetic stimulation in peripheral vessels, a decrease in the activity of the renin-angiotensin system.

When accepting funds, the need foroxygen of the myocardium due to a decrease in the frequency of contractions, sensitivity to sympathetic innervation. On the basis of arterial hypertension, the effect is observed after 2-5 days. Stable action of the drug occurs after one to two months of admission.

Appointment

Sotageksal medicine instructions for userecommends in ventricular tachyarrhythmias (induced and spontaneous), extrasystole, supraventricular tachycardia. The indications include a paroxysmal form of atrial fibrillation.

Contraindications

The "Sotagexal" agent is not prescribed (instructionon application warns about it) with cardiogenic shock, hypersensitivity, decompensated chronic or acute cardiac insufficiency, sinus bradycardia. Contraindications include pathologies in peripheral vessels of the occlusal type, pregnancy, metabolic acidosis, childhood and advanced age, psoriasis. It is not recommended a drug for COPD, arterial hypotension, bronchial asthma, lactation, depression, thyrotoxicosis. Do not prescribe a remedy for myasthenia gravis, hypokalemia, patients who had a history of allergic reactions to treatment. Contraindications include diabetes (sugar) with ketoacidosis.

Adverse Reactions

Sotageksal medicine (instructions for useindicates this) can cause increased fatigue, insomnia or drowsiness, paresthesia in the extremities, tremor, sinus bradycardia. On the background of therapy, headache, dizziness, loss of memory (short-term), confusion, disorders in peripheral circulation are likely. Undesirable consequences include atrioventricular blockade, arrhythmias, palpitations, visual impairment, soreness, dry eyes, nasal congestion, keratoconjunctivitis. During the therapy with Sotagexal medication (instructions for use warns about this) there may be a breakdown in the activity of the digestive tract, bronchospasm, rhinitis, epigastric and chest pain, orthostatic hypotension, difficulty breathing, change in taste. Patients may receive an allergic reaction in the form of a rash, burning and other skin manifestations, liver function disorder, hypoglycemia, hypothyroid condition, and increased sweating.

Dosing regimen

Medication is taken orally. As an antianginal agent, "Sotageksal" instructions for use recommends 80 mg twice a day. The same dosage is the initial dose for hypertension. If necessary, the amount of the drug is increased once a week by 80 mg. With other pathologies, dosages are set individually.